Pandemic hurts sales, profit for Pfizer amid restructuring
Pfizer Inc. reported a 32% plunge in second-quarter profit, mainly due to the global coronavirus pandemic limiting marketing of and new prescriptions for its medicines. |!| Oklahom…
Pfizer Inc. reported a 32% plunge in second-quarter profit, mainly due to the global coronavirus pandemic limiting marketing of and new prescriptions for its medicines. |!| Oklahom…